Top Markets
#1 Islamic Coin Islamic Coin +152.11%
#2 龙虾 (Lobster) 龙虾 (Lobster) +56.69%
#3 SODAX SODAX +52.42%
#4 Cortex Cortex +32.10%
#5 Targon Targon +25.53%
#6 Staked TAO (Root) Staked TAO (Root) +25.46%
#7 EfficientFrontier EfficientFrontier +25.30%
#8 τemplar τemplar +24.96%
#9 Chutes Chutes +24.96%
#10 affine affine +24.81%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Classifica tra le azioni #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Prezzo delle azioni
$36.75
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.63B
Variazione (1 giorno)
-0.78%
Variazione (1 anno)
-
Paese
US
Scambia Avalyn Pharma Inc. Common Stock (AVLN)

Categoria

Healthcare
Rapporto P/S per Avalyn Pharma Inc. Common Stock (AVLN)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Avalyn Pharma Inc. Common Stock, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Avalyn Pharma Inc. Common Stock da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH